Algorae Pharmaceuticals LimitedASX: 1AI

Change of Director's Interest Notice - DH

· Issued by Algorae Pharmaceuticals Limited via ASX

Filed with ASX · · 4 pages · English

Summary by 6ix AI

This filing is a Change of Director's Interest Notice for Algorae Pharmaceuticals Limited, detailing changes in the interests of director David Hainsworth in the company's securities. The notice indicates that there was an off-market transfer of shares and options between entities controlled by the director. It provides information on the number of securities held before and after the change, as well as the nature of the interests involved.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/change-of-directors-interest-notice-dh

Release

Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1 Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and...

Algorae Pharmaceuticals Limited on 6ix

Earlier from Algorae Pharmaceuticals

Later from Algorae Pharmaceuticals

All Algorae Pharmaceuticals news releases